Subscribe: Reuters: Health News
Added By: Feedage Forager Feedage Grade A rated
Language: English
arv drugs  drug  drugs  fraud lawsuit  health  lab tests  lab  medicare fraud  medicare  new  news  plea deal  pressure  reuters  trial 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Reuters: Health News

Reuters: Health News is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial in


Counting the costs: U.S. hospitals feeling the pain of physician burnout

Tue, 21 Nov 2017 06:34:01 -0500

ANN ARBOR, Mich. (Reuters) - Dr. Brian Halloran, a vascular surgeon at St. Joseph Mercy Ann Arbor, starts planning his garden long before spring arrives in southeast Michigan.(image)

Drug firm Concordia overcharged Britain's health service with 6,000 percent price rise

Tue, 21 Nov 2017 05:39:06 -0500

LONDON (Reuters) - Drug company Concordia overcharged Britain's health service millions of pounds for an essential thyroid drug by abusing its position as the only supplier, the country's Competition and Markets Authority said on Tuesday.(image)

2.5 million Yemenis now lack access to clean water: Red Cross

Tue, 21 Nov 2017 04:34:02 -0500

GENEVA (Reuters) - The capital Sanaa and al-Bayda have joined the list of Yemen cities without clean water due to the blockade by a Saudi-led coalition which has cut off supplies of fuel for pumping, the International Committee of the Red Cross (ICRC) said on Monday.(image)

Cytokinetics abandons ALS drug after failed trial

Tue, 21 Nov 2017 08:24:56 -0500

(Reuters) - Cytokinetics Inc said on Tuesday it would discontinue developing its drug to treat ALS, a fatal neuro-degenerative disorder, after the treatment failed in a late-stage trial.(image)

Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs

Tue, 21 Nov 2017 06:35:21 -0500

MÅLØV, Denmark (Reuters) - Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as its established diabetes drugs come under price pressure, particularly in the United States.(image)

Roche stock up $12 billion on cancer, hemophilia trials; rivals hit

Mon, 20 Nov 2017 11:06:55 -0500

ZURICH (Reuters) - Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker is counting on to offset shrinking revenue from older medicines.(image)

HCR ManorCare gets respite from dropped Medicare fraud lawsuit

Mon, 20 Nov 2017 14:02:48 -0500

CHICAGO (Reuters) - The U.S. Justice Department withdrew a Medicare fraud lawsuit against HCR ManorCare, removing a cloud over one the largest U.S. nursing home chains as it nears a deadline to settle a legal dispute with its landlord.(image)

U.S. judge rejects plea deal with Novelion's Aegerion

Mon, 20 Nov 2017 19:37:02 -0500

BOSTON (Reuters) - A judge on Monday rejected a plea deal that was part of Aegerion Pharmaceuticals Inc's recent agreement to pay $40.1 million to resolve U.S. probes of its marketing of a cholesterol drug, saying it was "not in the public interest."(image)

Reimbursement cuts on lab tests pressure U.S. lab firm shares

Mon, 20 Nov 2017 12:42:15 -0500

(Reuters) - A federal agency on Friday rolled out deep cuts to reimbursement rates for some lab tests under Medicare, a move that could save the government as much as $3 billion over five years, but hurt margins of U.S. laboratory companies.(image)

New ARV drugs, early diagnosis key to beating AIDS epidemic: UNAIDS

Mon, 20 Nov 2017 06:43:05 -0500

CAPE TOWN (Reuters) - Developing new antiretroviral (ARV) drugs and using technology for early diagnosis are among steps needed to sustain momentum in fighting HIV/AIDS and ending the disease as a public health threat by 2030, UNAIDS said in a report on Monday.(image)